ATE451922T1 - Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren - Google Patents
Verwendung von thiazolidinon-derivaten zur behandlung von festen tumorenInfo
- Publication number
- ATE451922T1 ATE451922T1 AT05820657T AT05820657T ATE451922T1 AT E451922 T1 ATE451922 T1 AT E451922T1 AT 05820657 T AT05820657 T AT 05820657T AT 05820657 T AT05820657 T AT 05820657T AT E451922 T1 ATE451922 T1 AT E451922T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- solid tumors
- sub
- thiazolidinone derivatives
- thiazolidinone
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title 1
- 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 abstract 1
- 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 abstract 1
- 230000001772 anti-angiogenic effect Effects 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002475A ITMI20042475A1 (it) | 2004-12-23 | 2004-12-23 | Uso di derivati tiazolidinonici come agenti terapeutici |
| PCT/EP2005/013650 WO2006066846A1 (en) | 2004-12-23 | 2005-12-19 | Use of thiazolidinone derivatives as antiangiogenic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE451922T1 true ATE451922T1 (de) | 2010-01-15 |
Family
ID=36168693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05820657T ATE451922T1 (de) | 2004-12-23 | 2005-12-19 | Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080261980A1 (de) |
| EP (1) | EP1830848B1 (de) |
| JP (1) | JP2008525340A (de) |
| KR (1) | KR20070100718A (de) |
| CN (1) | CN101083989A (de) |
| AT (1) | ATE451922T1 (de) |
| AU (1) | AU2005318432A1 (de) |
| CA (1) | CA2592004A1 (de) |
| DE (1) | DE602005018390D1 (de) |
| IL (1) | IL184116A0 (de) |
| IT (1) | ITMI20042475A1 (de) |
| MX (1) | MX2007007498A (de) |
| WO (1) | WO2006066846A1 (de) |
| ZA (1) | ZA200704914B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1916249A1 (de) * | 2006-10-10 | 2008-04-30 | LEK Pharmaceuticals D.D. | 3-(Benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-yliden-Derivate als antibakterielles Mittel |
| FR2929851B1 (fr) * | 2008-04-09 | 2012-11-30 | Centre Nat Rech Scient | Molecules inhibant une voie metabolique impliquant la proteine tyrosine kinase syk et procede d'identification de ces molecules |
| US8207205B2 (en) | 2008-04-21 | 2012-06-26 | Institute For Oneworld Health | Compounds, compositions and methods comprising oxadiazole derivatives |
| US8236838B2 (en) | 2008-04-21 | 2012-08-07 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
| PL2356113T3 (pl) * | 2008-11-14 | 2015-06-30 | Bayer Ip Gmbh | Heterocyklicznie podstawione związki arylowe jako inhibitory HIF |
| US8343976B2 (en) | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
| AR078770A1 (es) | 2009-10-27 | 2011-11-30 | Elara Pharmaceuticals Gmbh | Derivados de dihidrobenzo oxacinas y tiazinas, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades inflamatorias e hiperproliferativas. |
| WO2015023827A1 (en) * | 2013-08-14 | 2015-02-19 | North Carolina Central University | A high-throughput assay for identifying small molecules that modulate amp-activated protein kinase (ampk) |
| EP3307722B1 (de) | 2015-06-12 | 2021-08-04 | GB006, Inc. | Feste formen von (z) -4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-yliden ) methyl) furan-2-yl) benzoesäure |
| WO2021061665A1 (en) * | 2019-09-23 | 2021-04-01 | Gb006, Inc. | Integrin agonist prodrugs |
| WO2024037910A1 (en) * | 2022-08-17 | 2024-02-22 | Institut National de la Santé et de la Recherche Médicale | Syk inhibitors for use in the treatment of cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE794532A (fr) * | 1972-01-26 | 1973-07-25 | Boehringer Sohn Ingelheim | Nouvelles 3-hydroxymethyl-5-benzylidene-azolidinones et procede pour les fabriquer |
| WO1998053790A2 (en) * | 1997-05-30 | 1998-12-03 | Texas Biotechnology Corporation | Compounds that inhibit the binding of vascular endothelial growth factor to its receptors |
| JPH11302280A (ja) * | 1998-04-17 | 1999-11-02 | Ono Pharmaceut Co Ltd | チアゾリジン誘導体、およびその誘導体を有効成分とする医薬 |
| US6706766B2 (en) * | 1999-12-13 | 2004-03-16 | President And Fellows Of Harvard College | Small molecules used to increase cell death |
| US20040002526A1 (en) * | 2002-04-03 | 2004-01-01 | Cell Therapeutics, Inc. | Phospholipase D inhibitors and uses thereof |
| AU2003245555A1 (en) * | 2002-06-17 | 2003-12-31 | The Pennsylvania State Research Foundation | Sphingosine kinase inhibitors |
| BR0203747A (pt) * | 2002-09-10 | 2004-05-25 | Conselho Nacional Cnpq | Moléculas com atividade antitumoral e processo para a sua obtenção |
| EP1551396A1 (de) * | 2002-09-26 | 2005-07-13 | Pintex Pharmaceuticals, Inc. | Pin1-modulierende verbindungen und anwendungsverfahren daf r |
| WO2004043955A1 (en) * | 2002-11-13 | 2004-05-27 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
| EP1651226B1 (de) * | 2003-07-11 | 2010-02-24 | Proteologics, Inc. | Ubiquitin-ligase-hemmer und verwandte verfahren |
| EP1654380A4 (de) * | 2003-08-14 | 2009-09-09 | Insight Biopharmaceuticals Ltd | Verfahren und pharmazeutische zusammensetzungen zur modulation der heparanaseaktivierung und verwendungen davon |
| WO2005026127A1 (ja) * | 2003-09-11 | 2005-03-24 | Institute Of Medicinal Molecular Design. Inc. | プラスミノゲンアクチベータインヒビター－１阻害剤 |
| US20050282840A1 (en) * | 2004-02-11 | 2005-12-22 | Painceptor Pharma Corporation | Methods of modulating neurotrophin-mediated activity |
-
2004
- 2004-12-23 IT IT002475A patent/ITMI20042475A1/it unknown
-
2005
- 2005-12-19 ZA ZA200704914A patent/ZA200704914B/xx unknown
- 2005-12-19 CN CNA2005800440053A patent/CN101083989A/zh active Pending
- 2005-12-19 EP EP05820657A patent/EP1830848B1/de not_active Expired - Lifetime
- 2005-12-19 JP JP2007547309A patent/JP2008525340A/ja active Pending
- 2005-12-19 MX MX2007007498A patent/MX2007007498A/es not_active Application Discontinuation
- 2005-12-19 CA CA002592004A patent/CA2592004A1/en not_active Abandoned
- 2005-12-19 AU AU2005318432A patent/AU2005318432A1/en not_active Abandoned
- 2005-12-19 DE DE602005018390T patent/DE602005018390D1/de not_active Expired - Fee Related
- 2005-12-19 AT AT05820657T patent/ATE451922T1/de not_active IP Right Cessation
- 2005-12-19 US US11/793,874 patent/US20080261980A1/en not_active Abandoned
- 2005-12-19 WO PCT/EP2005/013650 patent/WO2006066846A1/en not_active Ceased
- 2005-12-19 KR KR1020077014023A patent/KR20070100718A/ko not_active Withdrawn
-
2007
- 2007-06-21 IL IL184116A patent/IL184116A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008525340A (ja) | 2008-07-17 |
| WO2006066846A1 (en) | 2006-06-29 |
| US20080261980A1 (en) | 2008-10-23 |
| AU2005318432A1 (en) | 2006-06-29 |
| KR20070100718A (ko) | 2007-10-11 |
| DE602005018390D1 (de) | 2010-01-28 |
| IL184116A0 (en) | 2007-10-31 |
| EP1830848B1 (de) | 2009-12-16 |
| CN101083989A (zh) | 2007-12-05 |
| EP1830848A1 (de) | 2007-09-12 |
| ITMI20042475A1 (it) | 2005-03-23 |
| CA2592004A1 (en) | 2006-06-29 |
| MX2007007498A (es) | 2007-10-10 |
| ZA200704914B (en) | 2008-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL184116A0 (en) | Use of thiazolidinone derivatives as antiangiogenic agents | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
| MXPA05008172A (es) | Derivados de malonamida como inhibidores gamma-secretasa. | |
| SE0104340D0 (sv) | New compounds | |
| ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| MXPA05012061A (es) | Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad. | |
| DE60329316D1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
| IL171977A0 (en) | Cyclic sulfonamides for inhibition of gamma-secretase | |
| GB0022438D0 (en) | Organic Compounds | |
| EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
| NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| IL166027A0 (en) | Bisarylsulfonamide compounds and their use in cancer therapy | |
| EA200601212A1 (ru) | Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение | |
| EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
| EA200601239A1 (ru) | Замещённые хинолиновые соединения | |
| EA200802329A1 (ru) | Производные триазола ii | |
| BRPI0410979A (pt) | composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia | |
| SE0403006D0 (sv) | New compounds | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| EP1689713A4 (de) | Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |